<DOC>
	<DOCNO>NCT00031967</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Drugs melatonin may make tumor cell sensitive radiation therapy may protect normal cell side effect radiation therapy . PURPOSE : Randomized phase II trial determine effectiveness combine melatonin radiation therapy treat patient brain metastasis .</brief_summary>
	<brief_title>Melatonin Radiation Therapy Treating Patients With Brain Metastases</brief_title>
	<detailed_description>OBJECTIVES : - Determine effect melatonin , use radiosensitization/radioprotection , overall survival clinical deterioration patient brain metastasis undergoing radiotherapy . OUTLINE : This randomize , multicenter study . Patients stratify accord plan chemotherapy whole brain irradiation ( yes v ) . Patients randomize 1 2 treatment arm . - Arm I : Patients undergo whole brain irradiation daily 5 day week 2 week . Patients receive oral melatonin daily every morning . - Arm II : Patients undergo whole brain irradiation arm I . Patients receive oral melatonin daily every evening . All patient continue melatonin 6 month absence disease progression unacceptable toxicity . Patients follow month 6 12 start radiotherapy every 6 month thereafter . PROJECTED ACCRUAL : A total 128 patient ( 64 per treatment arm ) accrue study within 5 month .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Radiation Injuries</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm solid tumor brain metastasis No germ cell tumor RPA class II following : At least 65 year age Extracranial metastasis Uncontrolled primary malignancy Ineligible unwilling participate alternative RTOG stereotactic radiosurgery study PATIENT CHARACTERISTICS : Age : See Disease Characteristics Performance status : Zubrod 01 Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : Able swallow pill Not pregnant Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : More 30 day since prior chemotherapy Concurrent chemotherapy whole brain irradiation allow Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics No prior radiotherapy brain Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
	<keyword>tumor metastatic brain</keyword>
	<keyword>radiation toxicity</keyword>
</DOC>